Page 37 - Peptide News Today

Relief Therapeutics Holding SA / Key word(s): Patent Relief Therapeutics Announces that its Subsidiary was Issued a Swiss Patent Entitled 'Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment

Peptide technology company Orbit Discovery has announced a partnership with WuXi AppTec that will see the combination of its peptide discovery platform and experience with the Chinese organisation’s downstream capabilities as a leading global provider of R&D and manufacturing services provision for the pharmaceutical and healthcare industry. Click to read more...

Next-generation mid-pilot scale peptide synthesizer provides more reliable, robust, and improved workflows Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and

JERSEY CITY, N.J., Feb. 16, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Peptide CDMO (Pharmaceutical) Market Trends

Revolo Biotherapeutics Receives MHRA Approval for Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in the United Kingdom

If you ever come across a king baboon spider (Pelinobius muticus), which lives primarily in Tanzania and Kenya, keep your distance: Its bite and the associated venom arent fatal but do produce a lot of pain and itchiness that can last for days.

October has arrived, and I can think of no better time to write an article about spiders. Spiders are a wondrous branch of life that belongs to the class Arachnida.

Zhittya Genesis Medicine Starts Parkinson’s Disease Clinical Trial

CHICAGO, Jan. 6, 2022 /PRNewswire/ -- According to the new market research report "Peptide Synthesis Market by Reagent (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography

EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, 'Vasoactive Intestinal Peptide